ARCHIVES

Two-Month Survival Benefit For Some NSCLC Patients

This article is from The Cancer Letter archive.

Vol. 25 No. 5 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

Totality Of Evidence Causes Concern About New Findings.

December 7, 2007

Varmus Appoints Group On Intellectual Property

May 8, 1998

Milken Calls For Renewed War On Cancer, $20 Billion A Year International Effort

November 24, 1995

RFP: Intellectual Property.

March 31, 2000

In Brief: Gene Therapy Pioneer Michael Blaese To Leave NIH For Biotechnology Firm

January 23, 1998

ACCC Members Hear How Community Cancer Programs Are Developed

February 11, 1977